Rock Springs Capital LLC, 10% Owner at Inozyme Pharma, Inc. (INZY), bought 1,067,884 shares at $16.00 ($9.6M) on 2020-07-28, disclosed to the SEC on 2020-07-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 467,884 | $0 | 0.0% |
| 2 | $16.00 | 24,000 | $384K | 4.0% |
| 3 | $16.00 | 576,000 | $9.2M | 96.0% |
| Total | $8.99 avg | 1,067,884 | $9.6M | 100% |
| Filing → |